Viral miRNAs and immune evasion

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1809, Issue 11-12, 2011, Pages 708-714

  Boss, Isaac W ^a   Renne, Rolf ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Immune evasion; miRNAs; Viral miRNA targets; Viruses

Indexed keywords

MICRORNA; VIRUS RNA;

ADAPTIVE IMMUNITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE TARGETING; HERPES VIRUS; IMMUNE EVASION; IMMUNOGENICITY; IMMUNOMODULATION; INNATE IMMUNITY; LATENT VIRUS INFECTION; LIFE CYCLE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; REVIEW; RNA CLEAVAGE; VIRUS GENE; VIRUS LATENCY;

ANIMALS; HERPESVIRIDAE; HUMANS; IMMUNE EVASION; MICRORNAS; MODELS, BIOLOGICAL; POLYOMAVIRUS; RNA, VIRAL; VIRUS DISEASES;

DNA VIRUSES; HERPESVIRIDAE; POLYOMAVIRUS;

EID: 80655127816     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2011.06.012     Document Type: Review

References (64)

1. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
2. Pasquinelli A.E., Reinhart B.J., Slack F., Martindale M.Q., Kuroda M.I., Maller B., Hayward D.C., Ball E.E., Degnan B., Muller P., Spring J., Srinivasan A., Fishman M., Finnerty J., Corbo J., Levine M., Leahy P., Davidson E., Ruvkun G. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 2000, 408:86-89.
3. Pfeffer S., Zavolan M., Grasser F.A., Chien M., Russo J.J., Ju J., John B., Enright A.J., Marks D., Sander C., Tuschl T. Identification of virus-encoded microRNAs. Science 2004, 304:734-736.
4. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
5. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
6. Mylin L.M., Schell T.D., Roberts D., Epler M., Boesteanu A., Collins E.J., Frelinger J.A., Joyce S., Tevethia S.S. Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes. J. Virol. 2000, 74:6922-6934.
7. Sullivan C.S., Grundhoff A.T., Tevethia S., Pipas J.M., Ganem D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 2005, 435:682-686.
8. Seo G.J., Fink L.H., O'Hara B., Atwood W.J., Sullivan C.S. Evolutionarily conserved function of a viral microRNA. J. Virol. 2008, 82:9823-9828.
9. Sullivan C.S., Sung C.K., Pack C.D., Grundhoff A., Lukacher A.E., Benjamin T.L., Ganem D. Murine Polyomavirus encodes a microRNA that cleaves early RNA transcripts but is not essential for experimental infection. Virology 2009, 387:157-167.
10. Lo A.K., To K.F., Lo K.W., Lung R.W., Hui J.W., Liao G., Hayward S.D. Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc. Natl Acad. Sci. U. S. A. 2007, 104:16164-16169.
11. Lung R.W., Tong J.H., Sung Y.M., Leung P.S., Ng D.C., Chau S.L., Chan A.W., Ng E.K., Lo K.W., To K.F. Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia (New York, N. Y.) 2009, 11:1174-1184.
12. Khanna R., Burrows S.R., Nicholls J., Poulsen L.M. Identification of cytotoxic T cell epitopes within Epstein-Barr virus (EBV) oncogene latent membrane protein 1 (LMP1): evidence for HLA A2 supertype-restricted immune recognition of EBV-infected cells by LMP1-specific cytotoxic T lymphocytes. Eur. J. Immunol. 1998, 28:451-458.
13. Meij P., Leen A., Rickinson A.B., Verkoeijen S., Vervoort M.B., Bloemena E., Middeldorp J.M. Identification and prevalence of CD8(+) T-cell responses directed against Epstein-Barr virus-encoded latent membrane protein 1 and latent membrane protein 2. Int. J. Cancer 2002, 99:93-99.
14. Stern-Ginossar N., Elefant N., Zimmermann A., Wolf D.G., Saleh N., Biton M., Horwitz E., Prokocimer Z., Prichard M., Hahn G., Goldman-Wohl D., Greenfield C., Yagel S., Hengel H., Altuvia Y., Margalit H., Mandelboim O. Host immune system gene targeting by a viral miRNA. Science 2007, 317:376-381.
15. Nachmani D., Lankry D., Wolf D.G., Mandelboim O. The human cytomegalovirus microRNA miR-UL112 acts synergistically with a cellular microRNA to escape immune elimination. Nat. Immunol. 2010, 11:806-813.
16. Dunn C., Chalupny N.J., Sutherland C.L., Dosch S., Sivakumar P.V., Johnson D.C., Cosman D. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. J. Exp. Med. 2003, 197:1427-1439.
17. Thomas M., Boname J.M., Field S., Nejentsev S., Salio M., Cerundolo V., Wills M., Lehner P.J. Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity. Proc. Natl Acad. Sci. U. S. A. 2008, 105:1656-1661.
18. Bauman Y., Nachmani D., Vitenshtein A., Tsukerman P., Drayman N., Stern-Ginossar N., Lankry D., Gruda R., Mandelboim O. An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe 2011, 9:93-102.
19. Qin Z., Kearney P., Plaisance K., Parsons C.H. Pivotal advance: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded microRNA specifically induce IL-6 and IL-10 secretion by macrophages and monocytes. J. Leukoc. Biol. 2010, 87:25-34.
20. Cirone M., Lucania G., Aleandri S., Borgia G., Trivedi P., Cuomo L., Frati L., Faggioni A. Suppression of dendritic cell differentiation through cytokines released by Primary Effusion Lymphoma cells. Immunol. Lett. 2008, 120:37-41.
21. Moore K.W., de Waal Malefyt R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001, 19:683-765.
22. Mosmann T.R. Properties and functions of interleukin-10. Adv. Immunol. 1994, 56:1-26.
23. Liang D., Gao Y., Lin X., He Z., Zhao Q., Deng Q., Lan K. A human herpesvirus miRNA attenuates interferon signaling and contributes to maintenance of viral latency by targeting IKKvarepsilon. Cell Res. 2011, 21:793-806.
24. Abend J.R., Uldrick T., Ziegelbauer J.M. Regulation of tumor necrosis factor-like weak inducer of apoptosis receptor protein (TWEAKR) expression by Kaposi's sarcoma-associated herpesvirus microRNA prevents TWEAK-induced apoptosis and inflammatory cytokine expression. J. Virol. 2010, 84:12139-12151.
25. Schwarz M., Murphy P.M. Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor constitutively activates NF-kappa B and induces proinflammatory cytokine and chemokine production via a C-terminal signaling determinant. J. Immunol. 2001, 167:505-513.
26. Sun Q., Matta H., Lu G., Chaudhary P.M. Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation. Oncogene 2006, 25:2717-2726.
27. Dolken L., Krmpotic A., Kothe S., Tuddenham L., Tanguy M., Marcinowski L., Ruzsics Z., Elefant N., Altuvia Y., Margalit H., Koszinowski U.H., Jonjic S., Pfeffer S. Cytomegalovirus microRNAs facilitate persistent virus infection in salivary glands. PLoS Pathog. 2010, 6:e1001150.
28. Xia T., O'Hara A., Araujo I., Barreto J., Carvalho E., Sapucaia J.B., Ramos J.C., Luz E., Pedroso C., Manrique M., Toomey N.L., Brites C., Dittmer D.P., Harrington W.J. EBV microRNAs in primary lymphomas and targeting of CXCL-11 by ebv-mir-BHRF1-3. Cancer Res. 2008, 68:1436-1442.
29. Grey F., Meyers H., White E.A., Spector D.H., Nelson J. A human cytomegalovirus-encoded microRNA regulates expression of multiple viral genes involved in replication. PLoS Pathog. 2007, 3:e163.
30. Murphy E., Vanicek J., Robins H., Shenk T., Levine A.J. Suppression of immediate-early viral gene expression by herpesvirus-coded microRNAs: implications for latency. Proc. Natl Acad. Sci. U. S. A. 2008, 105:5453-5458.
31. Grey F., Hook L., Nelson J. The functions of herpesvirus-encoded microRNAs. Med. Microbiol. Immunol. 2008, 197:261-267.
32. Stern-Ginossar N., Saleh N., Goldberg M.D., Prichard M., Wolf D.G., Mandelboim O. Analysis of human cytomegalovirus-encoded microRNA activity during infection. J. Virol. 2009, 83:10684-10693.
33. Cai X., Lu S., Zhang Z., Gonzalez C.M., Damania B., Cullen B.R. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc. Natl Acad. Sci. U. S. A. 2005, 102:5570-5575.
34. Cai X., Schafer A., Lu S., Bilello J.P., Desrosiers R.C., Edwards R., Raab-Traub N., Cullen B.R. Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog. 2006, 2:e23.
35. Cosmopoulos K., Pegtel M., Hawkins J., Moffett H., Novina C., Middeldorp J., Thorley-Lawson D.A. Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma. J. Virol. 2009, 83:2357-2367.
36. Edwards R.H., Marquitz A.R., Raab-Traub N. Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J. Virol. 2008, 82:9094-9106.
37. Grundhoff A., Sullivan C.S., Ganem D. A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 2006, 12:733-750.
38. Pfeffer S., Sewer A., Lagos-Quintana M., Sheridan R., Sander C., Grasser F.A., van Dyk L.F., Ho C.K., Shuman S., Chien M., Russo J.J., Ju J., Randall G., Lindenbach B.D., Rice C.M., Simon V., Ho D.D., Zavolan M., Tuschl T. Identification of microRNAs of the herpesvirus family. Nat. Methods 2005, 2:269-276.
39. Pratt Z.L., Kuzembayeva M., Sengupta S., Sugden B. The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines. Virology 2009, 386:387-397.
40. Samols M.A., Hu J., Skalsky R.L., Renne R. Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J. Virol. 2005, 79:9301-9305.
41. Xing L., Kieff E. Epstein-Barr virus BHRF1 micro- and stable RNAs during latency III and after induction of replication. J. Virol. 2007, 81:9967-9975.
42. Cai X., Cullen B.R. Transcriptional origin of Kaposi's sarcoma-associated herpesvirus microRNAs. J. Virol. 2006, 80:2234-2242.
43. Pearce M., Matsumura S., Wilson A.C. Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. J. Virol. 2005, 79:14457-14464.
44. Barth S., Pfuhl T., Mamiani A., Ehses C., Roemer K., Kremmer E., Jaker C., Hock J., Meister G., Grasser F.A. Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res. 2008, 36:666-675.
45. Iizasa H., Wulff B.E., Alla N.R., Maragkakis M., Megraw M., Hatzigeorgiou A., Iwakiri D., Takada K., Wiedmer A., Showe L., Lieberman P., Nishikura K. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J. Biol. Chem. 2010, 285:33358-33370.
46. Lei X., Bai Z., Ye F., Xie J., Kim C.G., Huang Y., Gao S.J. Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat. Cell Biol. 2010, 12:193-199.
47. Lu F., Stedman W., Yousef M., Renne R., Lieberman P.M. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J. Virol. 2010, 84:2697-2706.
48. de Oliveira D.E., Ballon G., Cesarman E. NF-kappaB signaling modulation by EBV and KSHV. Trends Microbiol. 2010, 18:248-257.
49. Linnstaedt S.D., Gottwein E., Skalsky R.L., Luftig M.A., Cullen B.R. Virally induced cellular microRNA miR-155 plays a key role in B-cell immortalization by Epstein-Barr virus. J. Virol. 2010, 84:11670-11678.
50. Yu F., Harada J.N., Brown H.J., Deng H., Song M.J., Wu T.T., Kato-Stankiewicz J., Nelson C.G., Vieira J., Tamanoi F., Chanda S.K., Sun R. Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus. PLoS Pathog. 2007, 3:e44.
51. Bellare P., Ganem D. Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 2009, 6:570-575.
52. Lin X., Liang D., He Z., Deng Q., Robertson E.S., Lan K. miR-K12-7-5p encoded by Kaposi's sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA. PLoS One 2011, 6:e16224.
53. Krause P.R., Stanberry L.R., Bourne N., Connelly B., Kurawadwala J.F., Patel A., Straus S.E. Expression of the herpes simplex virus type 2 latency-associated transcript enhances spontaneous reactivation of genital herpes in latently infected guinea pigs. J. Exp. Med. 1995, 181:297-306.
54. Sawtell N.M., Thompson R.L. Herpes simplex virus type 1 latency-associated transcription unit promotes anatomical site-dependent establishment and reactivation from latency. J. Virol. 1992, 66:2157-2169.
55. Thompson R.L., Sawtell N.M. The herpes simplex virus type 1 latency-associated transcript gene regulates the establishment of latency. J. Virol. 1997, 71:5432-5440.
56. Tang S., Bertke A.S., Patel A., Wang K., Cohen J.I., Krause P.R. An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor. Proc. Natl Acad. Sci. U. S. A. 2008, 105:10931-10936.
57. Tang S., Patel A., Krause P.R. Novel less-abundant viral microRNAs encoded by herpes simplex virus 2 latency-associated transcript and their roles in regulating ICP34.5 and ICP0 mRNAs. J. Virol. 2009, 83:1433-1442.
58. Umbach J.L., Kramer M.F., Jurak I., Karnowski H.W., Coen D.M., Cullen B.R. MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 2008, 454:780-783.
59. Jurak I., Kramer M.F., Mellor J.C., van Lint A.L., Roth F.P., Knipe D.M., Coen D.M. Numerous conserved and divergent microRNAs expressed by herpes simplex viruses 1 and 2. J. Virol. 2010, 84:4659-4672.
60. Tang S., Bertke A.S., Patel A., Margolis T.P., Krause P.R. Herpes simplex virus 2 microRNA miR-H6 is a novel latency-associated transcript-associated microRNA, but reduction of its expression does not influence the establishment of viral latency or the recurrence phenotype. J. Virol. 2011, 85:4501-4509.
61. Chi S.W., Zang J.B., Mele A., Darnell R.B. Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 2009, 460:479-486.
62. Hafner M., Landthaler M., Burger L., Khorshid M., Hausser J., Berninger P., Rothballer A., Ascano M., Jungkamp A.C., Munschauer M., Ulrich A., Wardle G.S., Dewell S., Zavolan M., Tuschl T. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010, 141:129-141.
63. Dolken L., Malterer G., Erhard F., Kothe S., Friedel C.C., Suffert G., Marcinowski L., Motsch N., Barth S., Beitzinger M., Lieber D., Bailer S.M., Hoffmann R., Ruzsics Z., Kremmer E., Pfeffer S., Zimmer R., Koszinowski U.H., Grasser F., Meister G., Haas J. Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 2010, 7:324-334.
64. Malterer G., Dolken L., Haas J. The miRNA-targetome of KSHV and EBV in human B-cells. RNA Biol. 2011, 8.